The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
Top Cited Papers
Open Access
- 20 July 2020
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 21 (8), 1023-1034
- https://doi.org/10.1016/s1470-2045(20)30388-0
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Diagnostic Intervals and Its Association with Breast, Prostate, Lung and Colorectal Cancer Survival in England: Historical Cohort Study Using the Clinical Practice Research DatalinkPLOS ONE, 2015
- Diagnostic delay and survival in high-grade gliomas – evidence of the ‘waiting time paradox’?British Journal of Neurosurgery, 2015
- Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic reviewBritish Journal of Cancer, 2015
- The benefits and harms of breast cancer screening: an independent reviewBritish Journal of Cancer, 2013
- The benefits and harms of breast cancer screening: an independent reviewThe Lancet, 2012
- Routes to diagnosis for cancer – determining the patient journey using multiple routine data setsBritish Journal of Cancer, 2012
- Adjusting for the proportion of cancer deaths in the general population when using relative survival: A sensitivity analysisCancer Epidemiology, 2012
- Delay in Diagnostic Workup and Treatment of Esophageal CancerJournal of Gastrointestinal Surgery, 2009
- Do diagnostic delays in cancer matter?British Journal of Cancer, 2009
- The relative survival rate: a statistical methodology.1961